Effect of continuous smoking reduction and abstinence on blood pressure and heart rate in smokers switching to electronic cigarettes
Individual Clinical
Biomarkers
Farsalinos (2016)
E-cigarettes emit very high formaldehyde levels only in conditions that are aversive to users: a replication study under verified realistic use conditions
Individual Clinical
User Topography
Farsalinos (2017)
Use Patterns, Flavors, Brands, and Ingredients of Nonnicotine e-Cigarettes among adolescents, Young adults, and adults in the United States.
Individual Clinical
User Topography
Gaiha (2022)
Electronic cigarette use among Italian smokers: patterns, settings, and adverse events.
Individual Clinical
User Topography
Gallus (2020)
Nicotine Intake in adult Pod E-Cigarette Users: Impact of User and Device Characteristics.
Individual Clinical
User Topography
Giberson (2023)
Prevalence and risk factors of e-cigarette use among working-age adults with and without disabilities in 2017-2018.
Individual Clinical
User Topography
Gimm (2021)
Electronic nicotine delivery systems (ENDS) flavours and devices used by adults before and after the 2020 US FDa ENDS enforcement priority: findings from the 2018 and 2020 US ITC Smoking and Vaping Surveys.
Individual Clinical
User Topography
Gravely (2022)
Trends in E-Cigarette Use among Various Subgroups.
Individual Clinical
User Topography
Gunasekaran (2020)
Tackling second-hand exposure to tobacco smoke and aerosols of electronic cigarettes: the TackShS project protocol.
Individual Clinical
Respiratory Toxicity
Secondary & Tertiary Exposure
Fernández (2020)
Biomarkers of Electronic Nicotine Delivery Systems (ENDS) use.
Individual Clinical
Biomarkers
ALL
Goniewicz (2023)